# An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

> **NCT01536418** · PHASE3 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 255 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** GSK1605786A
- **DRUG:** GSK1605786A

## Key facts

- **NCT ID:** NCT01536418
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11-11
- **Primary completion:** 2013-10-17
- **Final completion:** 2013-10-17
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2018-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536418, "An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01536418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*